Tim Evans
Stock Analyst at Wells Fargo
(2.35)
# 2,653
Out of 5,090 analysts
23
Total ratings
72.73%
Success rate
4.35%
Average return
Main Sectors:
Stocks Rated by Tim Evans
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $317.69 | -11.86% | 2 | Feb 28, 2018 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $317.05 | -11.69% | 2 | Feb 28, 2018 | |
| MEDP Medpace Holdings | Maintains: Market Perform | $38 → $35 | $548.12 | -93.61% | 3 | Feb 28, 2018 | |
| ILMN Illumina | Upgrades: Outperform | n/a | $128.96 | - | 2 | Jan 2, 2018 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $105 → $112 | $280.23 | -60.03% | 4 | Oct 27, 2017 | |
| DGX Quest Diagnostics | Maintains: Market Perform | $88 → $86 | $182.51 | -52.88% | 2 | Oct 20, 2017 | |
| LH Labcorp Holdings | Reinstates: Outperform | $175 | $258.39 | -32.27% | 1 | Oct 12, 2017 | |
| TECH Bio-Techne | Initiates: Market Perform | n/a | $61.68 | - | 1 | Jul 13, 2017 | |
| DHR Danaher | Initiates: Market Perform | $90 | $226.25 | -60.22% | 1 | Jul 13, 2017 | |
| MTD Mettler-Toledo International | Upgrades: Outperform | n/a | $1,414.86 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $48.03 | - | 2 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $145.49 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.36 | - | 1 | May 3, 2017 |
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $317.69
Upside: -11.86%
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $317.05
Upside: -11.69%
Medpace Holdings
Feb 28, 2018
Maintains: Market Perform
Price Target: $38 → $35
Current: $548.12
Upside: -93.61%
Illumina
Jan 2, 2018
Upgrades: Outperform
Price Target: n/a
Current: $128.96
Upside: -
West Pharmaceutical Services
Oct 27, 2017
Maintains: Outperform
Price Target: $105 → $112
Current: $280.23
Upside: -60.03%
Quest Diagnostics
Oct 20, 2017
Maintains: Market Perform
Price Target: $88 → $86
Current: $182.51
Upside: -52.88%
Labcorp Holdings
Oct 12, 2017
Reinstates: Outperform
Price Target: $175
Current: $258.39
Upside: -32.27%
Bio-Techne
Jul 13, 2017
Initiates: Market Perform
Price Target: n/a
Current: $61.68
Upside: -
Danaher
Jul 13, 2017
Initiates: Market Perform
Price Target: $90
Current: $226.25
Upside: -60.22%
Mettler-Toledo International
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1,414.86
Upside: -
Jul 13, 2017
Downgrades: Underperform
Price Target: n/a
Current: $48.03
Upside: -
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $145.49
Upside: -
May 3, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $1.36
Upside: -